351 related articles for article (PubMed ID: 15616755)
1. Tumor budding as an indicator of isolated tumor cells in lymph nodes from patients with node-negative colorectal cancer.
Park SY; Choe G; Lee HS; Jung SY; Park JG; Kim WH
Dis Colon Rectum; 2005 Feb; 48(2):292-302. PubMed ID: 15616755
[TBL] [Abstract][Full Text] [Related]
2. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
3. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
4. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
Yasuda K; Inomata M; Shiromizu A; Shiraishi N; Higashi H; Kitano S
Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
[TBL] [Abstract][Full Text] [Related]
6. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
[TBL] [Abstract][Full Text] [Related]
7. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
Camp RL; Rimm EB; Rimm DL
Cancer; 2000 Jan; 88(1):108-13. PubMed ID: 10618612
[TBL] [Abstract][Full Text] [Related]
8. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.
Messerini L; Cianchi F; Cortesini C; Comin CE
Hum Pathol; 2006 Oct; 37(10):1259-67. PubMed ID: 16949928
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.
Berberoglu U
Hepatogastroenterology; 2004; 51(60):1689-93. PubMed ID: 15532806
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing occult tumour cells and their predictive value in sentinel nodes of histologically negative patients with colorectal cancer.
van der Zaag ES; Kooij N; van de Vijver MJ; Bemelman WA; Peters HM; Buskens CJ
Eur J Surg Oncol; 2010 Apr; 36(4):350-7. PubMed ID: 20163930
[TBL] [Abstract][Full Text] [Related]
11. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
Yano H; Saito Y; Kirihara Y; Takashima J
Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
[TBL] [Abstract][Full Text] [Related]
12. Association between a high number of isolated lymph nodes in T1 to T4 N0M0 colorectal cancer and the microsatellite instability phenotype.
Eveno C; Nemeth J; Soliman H; Praz F; de The H; Valleur P; Talbot IC; Pocard M
Arch Surg; 2010 Jan; 145(1):12-7. PubMed ID: 20083749
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer.
Noura S; Yamamoto H; Miyake Y; Kim Bn; Takayama O; Seshimo I; Ikenaga M; Ikeda M; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2002 Mar; 8(3):759-67. PubMed ID: 11895906
[TBL] [Abstract][Full Text] [Related]
14. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas.
Masaki T; Matsuoka H; Sugiyama M; Abe N; Sakamoto A; Atomi Y
J Gastroenterol Hepatol; 2006 Jul; 21(7):1115-21. PubMed ID: 16824062
[TBL] [Abstract][Full Text] [Related]
15. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.
Wang HS; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Chang SC; Lin JK
Dis Colon Rectum; 2005 Jun; 48(6):1182-92. PubMed ID: 15793641
[TBL] [Abstract][Full Text] [Related]
16. Estimation of tumor stage and lymph node status in patients with colorectal adenocarcinoma using probabilistic neural networks and logistic regression.
Singson RP; Alsabeh R; Geller SA; Marchevsky A
Mod Pathol; 1999 May; 12(5):479-84. PubMed ID: 10349985
[TBL] [Abstract][Full Text] [Related]
17. [Study on independent factors on the prognosis of colorectal carcinoma: TNM stage, tumor budding, perineural invasion, peritumoral-lymphocytic infiltration and urine glucose].
Xu FY; Dong JK; Zhu YM; Qu MJ; Wang FJ; Jin YS; Ren GP; Lai MD
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 May; 26(5):366-9. PubMed ID: 16053766
[TBL] [Abstract][Full Text] [Related]
18. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
[TBL] [Abstract][Full Text] [Related]
19. Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer.
Ghadimi BM; Grade M; Liersch T; Langer C; Siemer A; Füzesi L; Becker H
Clin Cancer Res; 2003 May; 9(5):1808-14. PubMed ID: 12738738
[TBL] [Abstract][Full Text] [Related]
20. [Detection of isolated disseminated tumor cells of colorectal carcinomas in lymph nodes].
Weitz J; Kienle P; Magener A; Willeke F; Lehnert T; Herfarth C; von Knebel Doeberitz M
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):319-22. PubMed ID: 14518268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
